Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HVPG-guided therapy for secondary prophylaxis of variceal hemorrhage
NCT02638415Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in Gastroesophageal Variceal Hemorrhage, sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
carvedilol
03
Conditions
Gastroesophageal Variceal Hemorrhage
Beyond the preview
Go deeper on NCT02638415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638415.